Shenzhen Tiansu Calibration and Testing Co., Ltd. (SHE:301449)
42.80
0.00 (0.00%)
At close: Oct 8, 2026
SHE:301449 Revenue
Shenzhen Tiansu Calibration and Testing had revenue of 261.24M CNY in the quarter ending June 30, 2026, with 9.24% growth. This brings the company's revenue in the last twelve months to 877.63M, up 9.69% year-over-year. In the year 2025, Shenzhen Tiansu Calibration and Testing had annual revenue of 865.86M with 8.22% growth. That makes Shenzhen Tiansu Calibration and Testing the 20,608th largest company in the world by revenue and 3,766th in China.
Revenue (ttm)
877.63M
Revenue Growth
+9.69%
P/S Ratio
4.08
Revenue / Employee
338.98K
Employees
2,589
Market Cap
3.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 865.86M | 65.74M | 8.22% |
| Dec 31, 2024 | 800.12M | 74.41M | 10.25% |
| Dec 31, 2023 | 725.71M | 128.51M | 21.52% |
| Dec 31, 2022 | 597.20M | 101.98M | 20.59% |
| Dec 31, 2021 | 495.22M | 101.63M | 25.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cachet Pharmaceutical | 18.10B |
| CNFC Overseas Fisheries Co.,Ltd | 4.67B |
| Shaanxi Xinghua Chemistry Co.,Ltd | 3.89B |
| Changhua Chemical Technology | 3.12B |
| Guangbo Group Stock | 2.91B |
| Wiscom System | 1.61B |
| Petpal Pet Nutrition Technology | 1.46B |
| Nanjing Baose | 1.36B |